Language

MingDun won domain name disputes in Hong Kong

Recently, MingDun helped our client Novo Nordisk knock out infringing domain names and in Hong Kong. Mingdun successfully prevented the infringer from illegally using Novo Nordisk's goodwill to deceive patients.

Our client Novo Nordisk is a world-leading biopharmaceutical company dedicated to human health for the benefit of patients and society with advanced biotechnology. Novo Nordisk's history dates to 1923, and for a hundred years, it has been committed to innovation and lead the field of diabetes. This tradition also gives Novo the experience and ability to help people overcome other serious chronic diseases, such as hemophilia, growth hormone disorders and obesity. Novo Nordisk has about 43,200 employees in 80 countries and regions and provides products and services to more than 170 countries and regions around the world.

Saxenda is an innovative drug, which is produced and developed by Novo Nordisk for weight management. As early as 2013, Novo Nordisk applied for the trademark “Saxenda” in Denmark, Argentina, Canada, Japan, South Korea, Hong Kong and other countries and regions respectively. In addition, Novo Nordisk also registered the domain name on August 19, 2013. Saxenda has been approved and registered by the Pharmacy and Poisons Board of Hong Kong on 28 February 2017.

The disputed domain names, registered in 2018 and 2023, are both used to advertise Saxenda. The websites contain detailed descriptions of the product, manuals, instructions, and medical information, as well as the sale of Saxenda. After inquiry, the registrant of the disputed domain does not have specific drug trading and sales qualifications, and has no commercial relationship with our client.

In accordance with the provisions of the “Domain Name Dispute Resolution Policy”, we have submitted applications for domain name dispute arbitration to the Hong Kong International Arbitration Center. In the applications, we respectively submitted evidence of the use of the trademark Saxenda worldwide, evidence that the product Saxenda was listed in Hong Kong and has a certain popularity, and evidence of the malicious use of the disputed domain name registrant. Finally, the Hong Kong International Arbitration Center awarded:

  1. The main part of the disputed domain name is exactly the same as the trademark that our client has rights in Hong Kong and is easy to cause confusion;

  2. The disputed domain name registrar does not have the right to use the domain name;

  3. The use of the disputed domain name registrar is malicious.

Further, the Hong Kong International Arbitration Center decided to transfer the disputed domain name to our client.

At this point, our firm has once again successfully protected the the client's brand and the public's medical safety. Moreover, the case shows that MingDun has the ability to safeguard the rights of the client in Hong Kong. With its superior business environment, Hong Kong has attracted a large number of enterprises to invest and start businesses in Hong Kong. At the same time, a large number of offenders are also trying to take advantage of the unique advantages of Hong Kong and the goodwill of legitimate enterprises to deceive consumers and obtain illegal profits. This makes it particularly important for enterprises to have the ability to safeguard their rights in Hong Kong. MingDun will continue to strengthen our capacity of protecting rights in Hong Kong, helping enterprises effectively crack down on illegal activities of infringers and protect their legitimate rights and interests.


  • Related information More
  • 点击次数: 1000006
    2023 - 12 - 27
    Author:Miao QuMingdun Made a Speech on the Dilemma of Applying the Crime of Concealing the Proceeds of Crime to Diverted Drug CasesOn December 23, 2023, four lawyers from Mingdun Law Firm, including Liu Jinzhu, Zhang Lin, Wang Hui, and Qu Miao, participated in the Second Seminar on the Theory and Practice of Governance of New Types of Crimes as representatives of the members of Beijing Criminology Research Society.This seminar was organized by the Beijing Criminology Research Society, with the theme of "Exploring the Crime Governance System in the New Era and Serving the Rule of Law in the Capital". Superiors from the Supreme Prosecutor's Office, the Supreme Court, the People's Public Security University of China, the Chinese Society of Criminology and other relevant...
  • 点击次数: 1000007
    2023 - 10 - 17
    In September 2022, an insurance company sued our client, an insurance brokerage company as well as a technology company, requiring them to pay the premium collection and claim settlement amount of RMB 3 million.After accepting the entrustment, MingDun patiently listened to the client's briefing on the contract's signing, performance and dispute. Further, our firm carefully reviews the evidence materials of the case, deeply analyzes the evidence materials related to the litigation request, and works with the client to formulate response strategies and actively respond to the litigation. Ultimately, we drafted and submitted a reply and cross-examination opinion to the people's court, but did not participate in the trial.In July 2023, the court ruled that the plaintiff's claim...
  • 点击次数: 1000006
    2023 - 09 - 13
    Recently, MingDun helped our client Novo Nordisk knock out infringing domain names and in Hong Kong. Mingdun successfully prevented the infringer from illegally using Novo Nordisk's goodwill to deceive patients.Our client Novo Nordisk is a world-leading biopharmaceutical company dedicated to human health for the benefit of patients and society with advanced biotechnology. Novo Nordisk's history dates to 1923, and for a hundred years, it has been committed to innovation and lead the field of diabetes. This tradition also gives Novo the experience and ability to help people overcome other serious chronic diseases, such as hemophilia, growth hormone disorders and obesity. Novo Nordisk has about 43,200 employees in 80 countries and regions and provides products and services to more t...
  • 点击次数: 1000007
    2023 - 09 - 11
    Recently, the Market Supervision Administration of Jiujiang City, Jiangxi Province, at the request of MingDun, imposed a fine of CNY 120,000 on the Jiujiang Fuzeyuan Pharmacy for its retail of only 3 boxes of medicines purchased through illegal channels. This case was published as a typical case by Jiangxi Provincial Market Supervision Administration. Details of the case are as follows.In October 2022, MingDun found that the client’s products sold by the Fuzeyuan Pharmacy had actually flowed through the Affiliated Hospital of Jiujiang Medical College. In another word, the client’s products should be at the hand of the patients, and the Fuzeyuan Pharmacy should have purchased the client’s products from illegal channels. The Fuzeyuan Pharmacy should be retailing Diverted Medicine.Under norma...
× WeChat official account
Beijing Mingdun Law Firm www.mdlaw.cn
Copyright 2008 - 2020 Beijing Mingdun Law FirmRhino Cloud Provides Enterprise Cloud Services
X
1

QQ设置

3

SKYPE 设置

4

阿里旺旺设置

5

电话号码管理

6

二维码管理

展开